Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4546 USD | +3.01% | -2.82% | -95.88% |
05-24 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
05-14 | Allarity Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ALLARITY THERAPEUTICS, INC. | Bio Therapeutic Drugs | +3.01% | -2.82% | -95.88% | -99.71% | - | 8M |
- Stock Market
- Equities
- ALLR Stock
- Charts Allarity Therapeutics, Inc.
- Relative Strength Chart